Arrowstreet Capital’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-759,957
Closed -$13.4M 1893
2026
Q1
$13.4M Sell
759,957
-945,083
-55% -$19M 0.01% 859
2025
Q4
$33.7M Buy
1,705,040
+98,331
+6% +$1.77M 0.02% 594
2025
Q3
$28M Buy
1,606,709
+848,305
+112% +$12.6M 0.02% 628
2025
Q2
$10.6M Sell
758,404
-280,898
-27% -$4.52M 0.01% 890
2025
Q1
$19.4M Buy
1,039,302
+891,824
+605% +$13.3M 0.02% 603
2024
Q4
$1.66M Buy
147,478
+84,315
+133% +$986K ﹤0.01% 1323
2024
Q3
$747K Buy
+63,163
New +$597K ﹤0.01% 1455

Other funds holding ALHC

Arrowstreet Capital's ALHC Position: Q2 2026 in Review

Arrowstreet Capital sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 759,957 shares — an estimated $13.4M sold.

Arrowstreet Capital first reported a position in ALHC in Q3 2024 and held it in 7 quarters. The position peaked at $33.7M in Q4 2025. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Arrowstreet Capital reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 759,957 Alignment Healthcare shares in Q2 2026, an estimated $13.4M.
  • Arrowstreet Capital first reported a position in Alignment Healthcare in Q3 2024 and held it in 7 quarters.
  • Arrowstreet Capital's Alignment Healthcare position peaked at $33.7M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.